.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Queensland Health
Boehringer Ingelheim
Farmers Insurance
McKesson
Dow
US Department of Justice
Novartis
Chubb
UBS

Generated: November 18, 2017

DrugPatentWatch Database Preview

SUMYCIN Drug Profile

« Back to Dashboard

What is the patent landscape for Sumycin, and when can generic versions of Sumycin launch?

Sumycin is a drug marketed by Par Pharm and Apothecon and is included in three NDAs.

The generic ingredient in SUMYCIN is tetracycline hydrochloride. There are ninety-nine drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the tetracycline hydrochloride profile page.

Pharmacology for SUMYCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm
SUMYCIN
tetracycline hydrochloride
SUSPENSION;ORAL060400-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Par Pharm
SUMYCIN
tetracycline hydrochloride
TABLET;ORAL061147-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
SUMYCIN
tetracycline hydrochloride
CAPSULE;ORAL060429-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Par Pharm
SUMYCIN
tetracycline hydrochloride
TABLET;ORAL061147-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
SUMYCIN
tetracycline hydrochloride
CAPSULE;ORAL060429-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
SUMYCIN
tetracycline hydrochloride
CAPSULE;ORAL060429-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Par Pharm
SUMYCIN
tetracycline hydrochloride
TABLET;ORAL061147-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
SUMYCIN
tetracycline hydrochloride
CAPSULE;ORAL060429-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Par Pharm
SUMYCIN
tetracycline hydrochloride
TABLET;ORAL061147-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
UBS
US Army
Queensland Health
Federal Trade Commission
Cipla
Covington
Harvard Business School
Medtronic
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot